Products/Ovarian Cancer Cell Models
Ovarian Cancer Cell Models
Next Generation Ovarian Cancer Cell Lines That Elucidate Patient-to-Patient Differences Prior To Clinical Trials
Our ovarian cancer cell models overcome the limitations of traditional cell lines, transforming the quality and value of in vitro studies. Existing cell lines undermine efforts towards better, personalized, therapies for this complex, deadly disease. Poorly characterized and unrepresentative of the tumors of origin, the quality of existing cell lines is suspect, resulting in irreproducible studies.
Choosing The Right Cell Model For Your Ovarian Cancer Research
Existing cell lines only represent one patient. It is critical to analyze how a drug will respond in a range of patients with different characteristics. However, it is currently only possible to assess drug response in a wider population during clinical studies. Our next generation ovarian cancer cell lines, named Carousel and Powder, represent a range of patients with different characteristics. They have a clear ancestral link to defined patient tumors, and they elucidate patient-to-patient differences pre-clinical.
Carousel and Powder deliver the reproducibility and clinical relevance required to improve R&D success for a difficult disease. They represent a major breakthrough relative to existing cell lines with respect to:
- Authenticated heritage
- Patient specificity
- Faithful heterogeneity and relevance
- Accompanying documentation
- Characterized response to established therapies
In combination with Cellaria’s scientific know-how, the patient-specific cell model directly mirrors the established benefits of our existing portfolio of cell models.
Already know which cell model you need?
Don’t see the patient-specific cell line you need? Then take a look at our custom cell line development services.
Contextual Disease Data
We provide comprehensive proteomics profiles of each cell model, with details of how the performance data compares to other known patients, across multiple disease states. This enables scientists to know, based on data, how their drug will potentially perform in specific patient populations and empowers precision therapeutics programs.
Learn more about how we Characterize and authenticate our models